Cytometry Part A and Cytometry Part B: Clinical Cytometry combine forces to publish the first Joint Special Issue on Mass Cytometry (MC).

Cytometry Part A and Cytometry Part B: Clinical Cytometry combine forces to publish the first Joint Special Issue on Mass Cytometry (MC).
“STINGing” Liposomal Delivery for Cancer Immunotherapy
The 4th volume of Advanced Science is launched with issue 1.
Researchers from the Qin lab have developed a microfluidic cell deformation delivery method that uses physical constriction to deform and shear cells for delivery.
Cyanobacterial polymer as a drug delivery vehicle.
Yesilyurt et al. from MIT has demonstrated surface modification of model devices with an anti-biofouling zwitterionic polymer using a facile and scalable methodology.
In honor of Prof. K. Kataoka’s 65th birthday colleagues and friends have contributed to a special issue in Macromolecular Bioscience. Read the articles for free for a limited time.
In an effort to overcome barriers to the treatment of glioblastoma (GBM), targeted nanotherapeutics have emerged as promising drug delivery systems with the potential to improve pharmacokinetic profiles and therapeutic efficacy.
To design nanoproducts with improved therapeutic efficiency and controlled toxicity, we need to understand the mechanisms of cellular uptake and exocytosis of nanoparticles.
Researchers from Finland and the USA, have developed two multistage nanovaccines constructed of two biomaterials and either a biological cancer cell membrane (CCM) or a model antigen